Qilu Pharmaceutical Co., Ltd.

This study tests a new daily pill called QLS1410 in 260 adults whose high blood pressure remains high despite taking two or more medications. Participants will receive either QLS1410 or a placebo for 12 weeks. The main goal is to see if QLS1410 can lower systolic blood pressure m…

This study tests whether a new drug called QL1706, combined with chemotherapy, works better than another drug (tislelizumab) plus chemo for people with advanced non-small cell lung cancer that lacks the PD-L1 protein. About 606 adults aged 18-75 are taking part. The goal is to se…

This study tests a new drug called QL2106 against an approved drug, Tremfye® (guselkumab), in 190 healthy adults aged 18-45. The goal is to compare how the body processes each drug, their safety, and immune response after a single dose. Participants receive one injection and are …

This study tests a new injectable fertility drug (QL1012D) against an approved one (Gonal-F®) in 48 healthy women aged 18-45. The goal is to see if the new drug works the same way in the body and is just as safe. Participants receive both drugs at different times to compare them …